Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2008 1
2011 2
2012 3
2014 2
2015 1
2016 1
2017 2
2018 3
2022 4
2023 2
2024 2
2025 5
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Targeting DDR2 for Treating Pancreatic Cancer.
Do CTP, Pitta Venkata P, Prochnau JY, Singh D, Timilsina S, Subbarayalu P, Medina D, Abdulsahib S, Nirzhor S, Khan S, Li G, Polusani SR, Zhou D, Wang P, Chen Y, Vadlamudi RK, Hart MJ, Amaradhi R, McHardy SF, Rao MK. Do CTP, et al. Among authors: subbarayalu p. Mol Cancer Ther. 2025 Oct 1;24(10):1570-1583. doi: 10.1158/1535-7163.MCT-24-1226. Mol Cancer Ther. 2025. PMID: 40568905
Epigenetic silencing of DNA sensing pathway by FOXM1 blocks stress ligand-dependent antitumor immunity and immune memory.
Timilsina S, Huang JY, Abdelfattah N, Medina D, Singh D, Abdulsahib S, Subbarayalu P, Do TP, Venkata PP, Nirzhor S, Prochnau J, Bhandari M, Zheng S, Chen Y, Huang G, Mukherjee N, Hromas R, Sung P, Kaklamani V, Vadlamudi R, Zhang N, Rao MK. Timilsina S, et al. Among authors: subbarayalu p. Nat Commun. 2025 Apr 28;16(1):3967. doi: 10.1038/s41467-025-59186-3. Nat Commun. 2025. PMID: 40295473 Free PMC article.
The Discovery and Characterization of HBS-101, a Novel Inhibitor of Midkine, as a Therapeutic Agent for the Treatment of Triple-Negative Breast Cancer.
Mahajan M, Rodriguez Sanchez AL, Jayamohan S, Vijayan DK, Johnson JD, Xie H, Wang Y, Liang D, Sanchez JR 2nd, Subbarayalu P, Rao MK, Vadlamudi RK, Sareddy GR, Nair HB, Viswanadhapalli S. Mahajan M, et al. Among authors: subbarayalu p. Mol Cancer Ther. 2025 Sep 2;24(9):1308-1319. doi: 10.1158/1535-7163.MCT-25-0130. Mol Cancer Ther. 2025. PMID: 40304496 Free PMC article.
Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity.
Singh D, Onyeagucha BC, Medina D, Subbarayalu P, Mojidra R, Lv D, Bhandari M, Timilsina S, Pitta Venkata P, Huang JY, Nirzhor S, Abdulsahib S, Prochnau JY, Do CTP, Rajamanickam S, Chen Y, Taylor AB, Viswanadhapalli S, Falzone ME, Jiang J, Sung P, Zhou D, Vadlamudi RK, Hromas R, Rao MK. Singh D, et al. Among authors: subbarayalu p. Cancer Res. 2026 Mar 2;86(5):1252-1268. doi: 10.1158/0008-5472.CAN-25-0521. Cancer Res. 2026. PMID: 41329749
Androgen-responsive microRNAs in mouse Sertoli cells.
Panneerdoss S, Chang YF, Buddavarapu KC, Chen HI, Shetty G, Wang H, Chen Y, Kumar TR, Rao MK. Panneerdoss S, et al. PLoS One. 2012;7(7):e41146. doi: 10.1371/journal.pone.0041146. Epub 2012 Jul 20. PLoS One. 2012. PMID: 22911753 Free PMC article.
The PELP1 Pathway and Its Importance in Cancer Treatment.
Nassar KM, Subbarayalu P, Viswanadhapalli S, Vadlamudi RK. Nassar KM, et al. Among authors: subbarayalu p. Biomolecules. 2025 Dec 12;15(12):1729. doi: 10.3390/biom15121729. Biomolecules. 2025. PMID: 41463382 Free PMC article. Review.
Targeting the Leukemia Inhibitory Factor/Leukemia Inhibitory Factor Receptor Axis Reduces the Growth of Inflammatory Breast Cancer by Promoting Ferroptosis.
Romo B, Fuentes Z, Randolph L, Mahajan M, Aller EJ, Ebrahimi B, Santhamma B, Pratap UP, Subbarayalu P, Nagandla H, Thomas C, Nair HB, Vadlamudi RK, Viswanadhapalli S. Romo B, et al. Among authors: subbarayalu p. Cancers (Basel). 2025 Feb 25;17(5):790. doi: 10.3390/cancers17050790. Cancers (Basel). 2025. PMID: 40075639 Free PMC article.
Novel LIPA-Targeted Therapy for Treating Ovarian Cancer.
Collier AB, Viswanadhapalli S, Gopalam R, Lee TK, Kassees K, Parra K, Sharma G, Reese TC, Liu X, Yang X, Ebrahimi B, Pratap UP, Mahajan M, Arnold WC, Baker A, Chen CY, Elmore ST, Subbarayalu P, Sareddy GR, Valente PT, Kost ER, Ahn JM, Vadlamudi RK. Collier AB, et al. Among authors: subbarayalu p. Cancers (Basel). 2024 Jan 24;16(3):500. doi: 10.3390/cancers16030500. Cancers (Basel). 2024. PMID: 38339252 Free PMC article.
Targeting aberrant replication and DNA repair events for treating breast cancers.
Rajamanickam S, Park JH, Subbarayalu P, Timilsina S, Bates K, Yadav P, Nirzhor SSR, Eedunuri V, Mohammad TA, Jung KH, Onyeagucha B, Abdelfattah N, Benevides R, Lee G, Chen Y, Vadlamudi R, Brenner A, Kaklamani V, Jatoi I, Kuhn J, Hromas R, Gupta YK, Kaipparettu BA, Arbiser JL, Rao MK. Rajamanickam S, et al. Among authors: subbarayalu p. Commun Biol. 2022 May 24;5(1):493. doi: 10.1038/s42003-022-03413-w. Commun Biol. 2022. PMID: 35610507 Free PMC article.
31 results